chr17-4972328-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015099.4(CAMTA2):āc.2712G>Cā(p.Lys904Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,704 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015099.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAMTA2 | NM_015099.4 | c.2712G>C | p.Lys904Asn | missense_variant | 16/23 | ENST00000348066.8 | NP_055914.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAMTA2 | ENST00000348066.8 | c.2712G>C | p.Lys904Asn | missense_variant | 16/23 | 1 | NM_015099.4 | ENSP00000321813 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250768Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135552
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461504Hom.: 0 Cov.: 37 AF XY: 0.0000124 AC XY: 9AN XY: 727052
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.2781G>C (p.K927N) alteration is located in exon 16 (coding exon 16) of the CAMTA2 gene. This alteration results from a G to C substitution at nucleotide position 2781, causing the lysine (K) at amino acid position 927 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at